finance-abhi

Valiant Laboratories IPO

Valiant Laboratories is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company that was founded in 2021 and specialises in the production of paracetamol. Drugs in bulk or API are used as raw materials to create formulations or finished dosage forms.

The manufacturing facility for Valiant Laboratories is situated in Palghar, Maharashtra, India, and spans a total area of land totaling roughly 2,000 square metres. It has a total installed capacity of 9,000 MT per year.

The revenue from sales outside of India contributed 0.39%, 0.60%, and 0.33%, respectively, of the total revenue from operations for the financial years ended 31 March 2023, 2022, and 2021. Between FY 2017 and FY 2023, the revenue from operations increased at a CAGR of 23.90%.

Valiant Laboratories IPO Details

Signature Global IPO Details
Valiant Laboratories IPO Dates
27 Sep – 3 Oct 2023
Valiant Laboratories IPO Price
INR 133 – 140 per share
Fresh issue
10,890,000 shares INR 144.84 – 152.46 crore
Offer For Sale
NIL
Total IPO Size
11,556,000 shares INR 144.84 – 152.46 crore
Minimum bid (size)
105 shares INR 14,700
Face Value
INR 10 per share
Retail Allocation
35%
Listing On
BSE, NSE

Valiant Laboratories Financial Performance

Signature Global Financial Performance

FY21

FY22

FY23

Revenue

82.38

209.14

333.91

Expenses

72.04

179.73

300.64

Net income

4.75

22.59

29.03

Margin (%)

5.77

10.80

8.69

Figures in INR Crore unless specified otherwise

finance-abhi

Get the latest IPO and finance  news and stay informed about market trends and investment opportunities with Finance Abhi.

Follow Us